A detailed history of Legal & General Group PLC transactions in Zoetis Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 4,302,886 shares of ZTS stock, worth $709 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,302,886
Previous 4,302,886 -0.0%
Holding current value
$709 Million
Previous $841 Million -0.0%
% of portfolio
0.18%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $21.5 Million - $24.5 Million
124,806 Added 2.99%
4,302,886 $841 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $989,235 - $1.22 Million
6,797 Added 0.16%
4,178,080 $724 Million
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $6.02 Million - $7.27 Million
-36,348 Reduced 0.86%
4,171,283 $706 Million
Q4 2023

Feb 15, 2024

BUY
$151.44 - $200.09 $107 Million - $141 Million
706,200 Added 20.17%
4,207,631 $830 Million
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $26.4 Million - $30.4 Million
-157,946 Reduced 4.32%
3,501,431 $609 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $5.12 Million - $5.93 Million
-31,842 Reduced 0.86%
3,659,377 $630 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $10.1 Million - $12.2 Million
69,474 Added 1.92%
3,691,219 $614 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $24.9 Million - $29.9 Million
-190,165 Reduced 4.99%
3,621,745 $531 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $26.7 Million - $32.9 Million
-180,231 Reduced 4.51%
3,811,910 $565 Million
Q2 2022

Aug 22, 2022

BUY
$155.97 - $200.09 $6.32 Million - $8.11 Million
40,523 Added 1.03%
3,992,141 $686 Million
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $60.5 Million - $78 Million
333,376 Added 9.21%
3,951,618 $745 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $538,651 - $686,990
2,781 Added 0.08%
3,618,242 $883 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $42.2 Million - $46.7 Million
222,858 Added 6.57%
3,615,461 $702 Million
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $55 Million - $66.3 Million
352,658 Added 11.6%
3,392,603 $632 Million
Q1 2021

May 17, 2021

SELL
$144.0 - $169.39 $6.31 Million - $7.43 Million
-43,854 Reduced 1.42%
3,039,945 $479 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $5 Million - $5.55 Million
31,805 Added 1.04%
3,083,799 $510 Million
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $8.9 Million - $10.7 Million
-64,886 Reduced 2.08%
3,051,994 $505 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $3.95 Million - $5.03 Million
-35,257 Reduced 1.12%
3,116,880 $427 Million
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $7.69 Million - $12 Million
82,941 Added 2.7%
3,152,137 $371 Million
Q4 2019

Feb 13, 2020

BUY
$116.25 - $133.25 $10.9 Million - $12.5 Million
94,182 Added 3.17%
3,069,196 $406 Million
Q3 2019

Nov 13, 2019

SELL
$112.57 - $128.43 $2.13 Million - $2.43 Million
-18,896 Reduced 0.63%
2,975,014 $371 Million
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $12.9 Million - $15.1 Million
-131,843 Reduced 4.22%
2,993,910 $340 Million
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $46.8 Million - $57.8 Million
574,315 Added 22.51%
3,125,753 $315 Million
Q4 2018

Feb 15, 2019

BUY
$79.28 - $95.27 $17.8 Million - $21.4 Million
224,346 Added 9.64%
2,551,438 $218 Million
Q3 2018

Nov 20, 2018

BUY
$83.5 - $93.23 $6.88 Million - $7.69 Million
82,441 Added 3.67%
2,327,092 $213 Million
Q2 2018

Aug 10, 2018

SELL
$79.9 - $89.2 $8.77 Million - $9.79 Million
-109,726 Reduced 4.66%
2,244,651 $191 Million
Q1 2018

May 17, 2018

SELL
$71.51 - $84.69 $2.82 Million - $3.34 Million
-39,389 Reduced 1.65%
2,354,377 $196 Million
Q4 2017

Feb 13, 2018

BUY
$63.24 - $72.8 $151 Million - $174 Million
2,393,766
2,393,766 $172 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.